STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

35 hedge funds and large institutions have $3.32M invested in Statera Biopharma, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

93% less call options, than puts

Call options by funds: $1K | Put options by funds: $14K

Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
$14K
Net Calls
Net Calls Change

Top Buyers

1
+$1.24M
2
+$17K
3
+$12K
4
BFA
BlackRock Fund Advisors
California
+$10.8K
5
Citigroup
Citigroup
New York
+$6.45K

Top Sellers

1
-$750K
2
-$656K
3
-$184K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$135K
5
Renaissance Technologies
Renaissance Technologies
New York
-$26.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4K
27
$3K
28
$2K
29
$2K
30
$1K
31
$1K
32
$508
33
$341
34
–
35
–
36
–
37
–
38
–
39
–
1
2